The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis

Lee Jeong Won; Yun Mijin; Cho Arthur; Han Kwang-Hyub; Kim Do Young; Lee Sang Mi; Lee Jong Doo

首页> 外文期刊>Annals of nuclear medicine >The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis

【24h】

The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis

机译：FDG PET / CT代谢肿瘤体积对无肝外转移的肝细胞癌患者经动脉化学栓塞和经动脉化疗输注的预测价值

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this study was to evaluate the prognostic value of metabolic tumor volume (MTV) on pre-treatment F-18 fluorodeoxyglucose (FDG) PET/CT in patients with hepatocellular carcinoma (HCC).

机译：这项研究的目的是评估代谢性肿瘤体积（MTV）对肝细胞癌（HCC）患者的F-18氟脱氧葡萄糖（FDG）预处理PET / CT的预后价值。

著录项

来源
《Annals of nuclear medicine》 |2015年第5期|共9页
作者
Lee Jeong Won; Yun Mijin; Cho Arthur; Han Kwang-Hyub; Kim Do Young; Lee Sang Mi; Lee Jong Doo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
F-18 fluorodeoxyglucose; PET; Metabolic tumor volume; Prognosis; Hepatocellular carcinoma;

机译：F-18氟脱氧葡萄糖;PET;代谢性肿瘤;预后;肝细胞癌;

相似文献

外文文献
中文文献
专利

1. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis [J] . Lee Jeong Won, Yun Mijin, Cho Arthur, Annals of nuclear medicine . 2015,第5期

机译：FDG PET / CT代谢肿瘤体积对无肝外转移的肝细胞癌患者经动脉化学栓塞和经动脉化疗输注的预测价值
2. Early Decreases in α-Fetoprotein and Des-γ-carboxy Prothrombin Predict the Antitumor Effects of Hepatic Transarterial Infusion Chemotherapy with Cisplatin (CDDP) Powder in Patients with Advanced Hepatocellular Carcinoma [J] . Takeshi Hatanaka, Satoru Kakizaki, Yasushi Shimada, Internal medicine. . 2016,第16期

机译：α-甲胎蛋白和Des-γ-羧基凝血酶原的早期下降预测顺铂（CDDP）粉末对肝癌晚期患者的肝动脉灌注化疗的抗肿瘤作用
3. Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma [J] . Fujita Masashi, Takahashi Atsushi, Hayashi Manabu, Hepatology research: the official journal of the Japan Society of Hepatology . 2019,第7期

机译：肿瘤化疗栓塞期间的骨骼肌体积损失预测肝细胞癌患者的预后差
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Use of 18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization [O] . Min Jin Kim, Young Seok Kim, Youn Hee Cho, 2015

机译：使用18F-FDG PET预测经动脉化疗栓塞治疗的中级肝细胞癌患者的肿瘤进展和生存
7. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases. [O] . Jeong-Ju Yoo, Jeong-Hoon Lee, Sang Hwan Lee, 2014

机译：经肝动脉化疗栓塞治疗晚期肝细胞癌对肝外转移和非肝转移的疗效比较。

The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis

摘要

著录项

相似文献

相关主题

期刊订阅